Citation Impact
Citing Papers
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
2013 Standout
The endocannabinoid system in chronic liver disease
2005
Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats
2001
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity
2005
Striking Oxygen Sensitivity of the Peptidylglycine α-Amidating Monooxygenase (PAM) in Neuroendocrine Cells
2015 StandoutNobel
Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: Comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142
2009
ω-6 Polyunsaturated fatty acids extend life span through the activation of autophagy
2013 StandoutNobel
Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats
2001
Heterogeneity of hepatitis delta antigen
1990
Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2‐arachidonoyl glycerol
2002
Blood Levels of the Endocannabinoid Anandamide are Increased in Anorexia Nervosa and in Binge-Eating Disorder, but not in Bulimia Nervosa
2005
Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action
1998
Brain Cannabinoid Systems as Targets for the Therapy of Neurological Disorders
1998
Endocannabinoid system and alcohol addiction: Pharmacological studies
2005
Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study
1995
The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats
2003
Chapter 7 Cannabinoid Receptor CB1 Antagonists
2009
Bioisosteric replacement of the hydrazide pharmacophore of the cannabinoid-1 receptor antagonist SR141716A. Part I: Potent, orally-active 1,4-disubstituted imidazoles
2009
Brown and beige fat: development, function and therapeutic potential
2013 Standout
Adverse Health Effects of Marijuana Use
2014 Standout
A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders
2005
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
The anti‐obesity effect of rimonabant is associated with an improved serum lipid profile
2004
The β-Thalassemias
1999 Standout
Involvement of central cannabinoid (CB 1 ) receptors in the establishment of place conditioning in rats
1998
Neural regulation of endocrine and autonomic stress responses
2009 Standout
The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract
2005
Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice
2003
Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors
2005
The Cannabinoid CB1 Receptor Antagonist SR141716 Increases Acrp30 mRNA Expression in Adipose Tissue of Obese fa/fa Rats and in Cultured Adipocyte Cells
2003
Psychobiogenetics: adapted tools for the study of the coupling between behavioral and neuroendocrine traits of emotional reactivity
1994
Down-regulation of cannabinoid-1 (CB-1) receptors in specific extrahypothalamic regions of rats with dietary obesity: a role for endogenous cannabinoids in driving appetite for palatable food?
2002
ETHANOL INDUCES HIGHER BEC IN CB1 CANNABINOID RECEPTOR KNOCKOUT MICE WHILE DECREASING ETHANOL PREFERENCE
2004
Rimonabant: a selective blocker of the cannabinoid CB1 receptors for the management of obesity, smoking cessation and cardiometabolic risk factors
2006
Inverse agonism and neutral antagonism at cannabinoid CB1 receptors
2004
The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders
2003
Neuroendocrine regulation of eating behavior
2002
Cannabinoid Transmission and Reward-Related Events
1998
Decreased alcohol self-administration and increased alcohol sensitivity and withdrawal in CB1 receptor knockout mice
2003
Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes
2013
Design and Synthesis of a Homogeneous Erythropoietin Analogue with Two Human Complex‐Type Sialyloligosaccharides: Combined Use of Chemical and Bacterial Protein Expression Methods
2009 StandoutNobel
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
2008 Standout
Molecular biology of cannabinoid receptors
2002
The endocannabinoid system and its therapeutic exploitation
2004
Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats
2005
Synergistic effects of cannabinoid inverse agonist AM251 and opioid antagonist nalmefene on food intake in mice
2004
Non-alcoholic fatty liver disease: The mist gradually clears
2008
Involvement of the endocannabinoid system in drug addiction
2006
Dynamics of plasma catecholamine and corticosterone concentrations during reinforced and extinguished operant behavior in rats
1990
Obesity
2005 Standout
Motivational Effects of Cannabinoids and Opioids on Food Reinforcement Depend on Simultaneous Activation of Cannabinoid and Opioid Systems
2005
The cannabinoid system: a role in both the homeostatic and hedonic control of eating?
2003
Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice
2003
Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine
2002
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
New insights into copper monooxygenases and peptide amidation: structure, mechanism and function
2000
Genetic Impairment of Frontocortical Endocannabinoid Degradation and High Alcohol Preference
2006
Unsaturated Long-Chain N-Acyl-vanillyl-amides (N-AVAMs): Vanilloid Receptor Ligands That Inhibit Anandamide-Facilitated Transport and Bind to CB1 Cannabinoid Receptors
1999 StandoutNobel
From mice to men: What can we learn about personality from animal research?
2001 Standout
Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist
1999
Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice
2000
Nicotine-Associated Cues Maintain Nicotine-Seeking Behavior in Rats Several Weeks after Nicotine Withdrawal: Reversal by the Cannabinoid (CB1) Receptor Antagonist, Rimonabant (SR141716)
2004
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
The role of CB1 receptors in sweet versus fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940)
2005
Leptin potentiates the anti-obesity effects of rimonabant
2011
Endogenous cannabinoids are not involved in cocaine reinforcement and development of cocaine-induced behavioural sensitization
2004
Lack of CB1 Cannabinoid Receptor Impairs Cocaine Self-Administration
2005
Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats
2003
The endocannabinoid system: function in survival of the embryo, the newborn and the neuron
2002
Cannabinoid (CB)1 receptor antagonist, AM 251, causes a sustained reduction of daily food intake in the rat
2004
Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus
2005
Synergistic efects of opioid and cannabinoid antagonists on food intake
2001
CB1 Receptor Knockout Mice Display Reduced Ethanol-Induced Conditioned Place Preference and Increased Striatal Dopamine D2 Receptors
2004
The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin
2004
The cannabinoid CB1 receptor antagonist SR141716A reduces appetitive and consummatory responses for food
2004
Post-translational modifications in the context of therapeutic proteins
2006
Endocannabinoid lipids and mediated system: Implications for alcoholism and neuropsychiatric disorders
2005
Mice carrying a knock-in mutation of Aicda resulting in a defect in somatic hypermutation have impaired gut homeostasis and compromised mucosal defense
2011 StandoutNobel
Hyperphagia in pre-fed rats following oral δ9-THC
1998
Down-regulation of cannabinoid receptor agonist-stimulated [ ]GTPγS binding in synaptic plasma membrane from chronic ethanol exposed mouse
1999
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
THE ENDOCANNABINOID SYSTEM: PHYSIOLOGY AND PHARMACOLOGY
2004
Incidence of insulin-dependent diabetes mellitus among Sardinianheritage children born in Lazio region, Italy
1997
Hypersensitization of the Orexin 1 Receptor by the CB1 Receptor
2003
The metabolic syndrome—a new worldwide definition
2005 Standout
Increased ethanol consumption and preference and decreased ethanol sensitivity in female FAAH knockout mice
2006
Mechanisms and Functions of Inflammasomes
2014 Standout
What We Talk About When We Talk About Fat
2014 Standout
Integrated physiology and pathophysiology of CB1-mediated effects of the endocannabinoid system
2007
SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats
2002
Postsynthetic modification of metal–organic frameworks
2009 Standout
Cannabinoid type 1 receptor blockade induces transdifferentiation towards a brown fat phenotype in white adipocytes
2009
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
2007 Standout
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study
2005
Cardiovascular Disease Under the Influence of Excess Visceral Fat
2007
5 Thalassaemia: clinical management
1998
Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats
2001
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
2008
Cannabinoid CB1 Receptor Antagonists as Promising New Medications for Drug Dependence
2005
Cocaine- and Amphetamine-Related Transcript Is Involved in the Orexigenic Effect of Endogenous Anandamide
2005
Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview
2002
The Risk of Transfusion-Transmitted Viral Infections
1996 Standout
Lack of tolerance to the suppressing effect of rimonabant on chocolate intake in rats
2006
The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis
2003
Reversal of Δ9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine
2002
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Ghrelin: Structure and Function
2005 Standout
Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors
1999
Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors
2005
Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding
2000
The endocannabinoid system in obesity and type 2 diabetes
2008
Molecular and cellular basis of cannabinoid and opioid interactions
2005
Corticosterone levels during extinction of runway response in rats
1997
Endocannabinoids in the regulation of appetite and body weight
2005
Integration of Endocannabinoid and Leptin Signaling in an Appetite-Related Neural Circuit
2005
Inflammasomes: mechanism of action, role in disease, and therapeutics
2015 Standout
Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice
2005
CB1 cannabinoid receptor‐mediated modulation of food intake in mice
2005
Appetite suppression and weight loss after the cannabinoid antagonist SR 141716
1998
Endocannabinoid system and stress and anxiety responses
2005
Effect of Rimonabant, a Cannabinoid-1 Receptor Blocker, on Weight and Cardiometabolic Risk Factors in Overweight or Obese Patients
2006
Endocannabinoids May Mediate the Ability of (n-3) Fatty Acids to Reduce Ectopic Fat and Inflammatory Mediators in Obese Zucker Rats
2009
Functional consequences of the acute administration of the cannabinoid receptor antagonist, SR141716A, in cannabinoid-naive and -tolerant animals: a quantitative 2-[14C]deoxyglucose study
2003
The obesity pipeline: current strategies in the development of anti-obesity drugs
2006
Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice
2003
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol‐seeking behavior in rats
2005
Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lepob/Lepob mice
2004
The Human Obesity Gene Map: The 2004 Update
2005
Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores
2008
Human Studies of Cannabinoids and Medicinal Cannabis
2005
The cannabinoid receptor antagonist SR�141716 attenuates overfeeding induced by systemic or intracranial morphine
2003
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH)
2005
Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children
1994
Cannabinoid agonist, CP 55,940, facilitates intake of palatable foods when injected into the hindbrain
2004
Endocannabinoid control of food intake and energy balance
2005
The endocannabinoid system links gut microbiota to adipogenesis
2010
A single antigenomic open reading frame of the hepatitis delta virus encodes the epitope(s) of both hepatitis delta antigen polypeptides p24 delta and p27 delta
1988 StandoutNobel
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Generation of an MHC Class II-Restricted T Cell Epitope by Extracellular Processing of Hepatitis δ Antigen
1998 StandoutNobel
REDUCTION OF VOLUNTARY ETHANOL INTAKE IN ETHANOL-PREFERRING sP RATS BY THE CANNABINOID ANTAGONIST SR-141716
1998
Endogenous cannabinoids and appetite.
2001
The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
2005
Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in Apparently Healthy Adults
2011 Standout
Structure and Spectroscopy of Copper−Dioxygen Complexes
2004 Standout
Copper Active Sites in Biology
2014 Standout
Rimonabant for overweight or obesity
2006
Intensely pleasurable responses to music correlate with activity in brain regions implicated in reward and emotion
2001 Standout
Effects of SR141716A on Ethanol and Sucrose Self‐Administration
2001
Central and Peripheral Signaling Mechanisms Involved in Endocannabinoid Regulation of Feeding: A Perspective on the Munchies
2005
Structure, sequence and expression of the hepatitis delta (δ) viral genome
1986 StandoutNatureNobel
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Previously Infected and Recovered Chimpanzees Exhibit Rapid Responses That Control Hepatitis C Virus Replication upon Rechallenge
2002 StandoutNobel
Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles
1997 StandoutNobel
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats
2005
Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules
1995 StandoutNobel
Fatty Liver
2007
The clinical significance of immunoglobulin A deficiency
2007
Kinetics of CD4+and CD8+Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees
2003 StandoutNobel
Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol‐induced dopamine release in the nucleus accumbens
2003
Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors
2005
Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice
2003
Effects of Rimonabant on Metabolic Risk Factors in Overweight Patients with Dyslipidemia
2005
Rab3B protein is required for long-term depression of hippocampal inhibitory synapses and for normal reversal learning
2011 StandoutNobel
A Peripheral Mechanism for CB1 Cannabinoid Receptor-Dependent Modulation of Feeding
2002
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Effects of SR141716A on Ethanol and Sucrose Self-Administration
2001
Host-Gut Microbiota Metabolic Interactions
2012 StandoutScience
CANNABINOID RECEPTORS AS THERAPEUTIC TARGETS
2005
Cannabinoids as Novel Anti-Inflammatory Drugs
2009
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity
2005
Regulation, Function, and Dysregulation of Endocannabinoids in Models of Adipose and β-Pancreatic Cells and in Obesity and Hyperglycemia
2006
Evidence for an Interaction between CB1 Cannabinoid and Melanocortin MCR-4 Receptors in Regulating Food Intake
2004
Iron-Chelating Therapy and the Treatment of Thalassemia
1997
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Plant, Synthetic, and Endogenous Cannabinoids in Medicine
2005
Tetrahydrocannabinol and endocannabinoids in feeding and appetite
2002
Activation of the Peripheral Endocannabinoid System in Human Obesity
2005
Endogenous cannabinoids and appetite
2001
Dysregulation of the Peripheral and Adipose Tissue Endocannabinoid System in Human Abdominal Obesity
2006
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
2010 Standout
Endocannabinoids and Food Intake: Newborn Suckling and Appetite Regulation in Adulthood
2005
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
1989 StandoutScienceNobel
Intrahepatic Genetic Inoculation of Hepatitis C Virus RNA Confers Cross-Protective Immunity
2001 StandoutNobel
Works of M. Arnone being referenced
Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors
1997
The HLA DQB 1*0502 allele is neutrally associated with insulin‐dependent diabetes mellitus in the Sardinian population
1992
CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity
2004
Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats
2007
Evaluation of Antibodies to Hepatitis C Virus in a Long-Term Prospective Study of Posttransfusion Hepatitis Among Thalassemic Children
1993
SR147778 [5-(4-Bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1 H-pyrazole-3-carboxamide], a New Potent and Selective Antagonist of the CB1 Cannabinoid Receptor: Biochemical and Pharmacological Characterization
2004
Hepatitis B virus DNA in the serum of Sardinian blood donors negative for the hepatitis B surface antigen
1989
Evaluation of IgA deficiency in Sardinians indicates a susceptibility gene is encoded within the HLA class III region
1998
Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice
2003
CLINICAL SIGNIFICANCE OF ANTIBODY TO THE HEPATITIS DELTA VIRUS IN SYMPTOMLESS HBsAg CARRIERS
1985
The CB1 receptor antagonist rimonabant reverses the diet‐induced obesity phenotype through the regulation of lipolysis and energy balance
2005
Effects of frustration on behaviour and plasma corticosteroid levels in pigs
1980
SR146131: A New Potent, Orally Active, and Selective Nonpeptide Cholecystokinin Subtype 1 Receptor Agonist. II: In Vivo Pharmacological Characterization
1999